(Q40430014)

20 September 2017

title

Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo (English)

1 reference

20 September 2017

1

1 reference

20 September 2017

Florian A. Siebzehnrübl

4

1 reference

20 September 2017

5

1 reference

20 September 2017

9

Michael Weller

1 reference

20 September 2017

8

Wolfgang Wick

1 reference

20 September 2017

11

Ingmar Blümcke

1 reference

20 September 2017

Eric Hahnen

2

1 reference

20 September 2017

Rolf Buslei

3

1 reference

20 September 2017

Mike Lüders

6

1 reference

20 September 2017

Christian Tränkle

7

1 reference

20 September 2017

Rudolf Fahlbusch

10

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

Journal of Neurochemistry

20 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

20 September 2017

volume

93

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

992-999

1 reference

Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

The human histone deacetylase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

A histone deacetylase inhibitor enhances killing of undifferentiated thyroid carcinoma cells by p53 gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Brain tumor invasion model system using organotypic brain-slice culture as an alternative to in vivo model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Functional significance of histone deacetylase diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Morphological characterization of nitrosourea-induced glioma cell lines and clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Role of the histone deacetylase complex in acute promyelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Malignant glioma: genetics and biology of a grave matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Histone deacetylases and cancer: causes and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Histone deacetylase inhibitors as new cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Expression of vimentin and glial fibrillary acidic protein in ethylnitrosourea-induced rat gliomas and glioma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Histone deacetylases (HDACs): characterization of the classical HDAC family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Gcn5p is involved in the acetylation of histone H3 in nucleosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Characterization of a spontaneous murine astrocytoma and abrogation of its tumorigenicity by cytokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Clonal expansion of p53 mutant cells is associated with brain tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Anticonvulsant drugs fail to modulate chemotherapy-induced cytotoxicity and growth inhibition of human malignant glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

A simple method for organotypic cultures of nervous tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

Phosphorylation of histone H3 at serine 10 is correlated with chromosome condensation during mitosis and meiosis in Tetrahymena

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03098.X

10.1111/J.1471-4159.2005.03098.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference